tiprankstipranks
Advertisement
Advertisement
Summit Therapeutics falls -10.2%
PremiumThe FlySummit Therapeutics falls -10.2%
1M ago
Summit Therapeutics put volume heavy and directionally bearish
Premium
The Fly
Summit Therapeutics put volume heavy and directionally bearish
1M ago
Closing Bell Movers: Super Micro slips 5% after $7B equity offering
Premium
The Fly
Closing Bell Movers: Super Micro slips 5% after $7B equity offering
1M ago
Buy Rating Reaffirmed on Ivonescimab’s Practice-Changing NSCLC Survival Data; $40 Price Target Unchanged
PremiumRatingsBuy Rating Reaffirmed on Ivonescimab’s Practice-Changing NSCLC Survival Data; $40 Price Target Unchanged
1M ago
Summit Therapeutics Reports Strong Interim Ivonescimab Phase II Data
Premium
Company Announcements
Summit Therapeutics Reports Strong Interim Ivonescimab Phase II Data
1M ago
Jefferies’ Walch Initiates Sell on Summit Therapeutics, Sees Ivonescimab Phase 3 Data Falling Short and Sets $7.70 DCF-Based Price Target
Premium
Ratings
Jefferies’ Walch Initiates Sell on Summit Therapeutics, Sees Ivonescimab Phase 3 Data Falling Short and Sets $7.70 DCF-Based Price Target
1M ago
Midday Fly By: Estee Lauder walks from Puig, Imax reportedly explores sale
PremiumThe FlyMidday Fly By: Estee Lauder walks from Puig, Imax reportedly explores sale
2M ago
Texas Instruments, Generac upgraded: Wall Street’s top analyst calls
Premium
The Fly
Texas Instruments, Generac upgraded: Wall Street’s top analyst calls
2M ago
Summit Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Summit Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100